Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Küpfer

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1980
A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoinA Küpfer, G M Brilis, J T Watson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1984
Mephenytoin hydroxylation deficiency: kinetics after repeated dosesA Küpfer, P Desmond, R Patwardhan, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanolP G Wells, A Küpfer, J A Lawson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 1998
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in ratsT M Visarius, H Bähler, A Küpfer, et al.
British Journal of Cancer|September 1, 1993
Depletion of circulating cyst(e)ine by oral and intravenous mesnaB Stofer-Vogel, T Cerny, A Küpfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapyB H Lauterburg, T Nguyen, B Hartmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1984
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humansA Küpfer, R Patwardhan, S Ward, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
Analytical Biochemistry|June 23, 2011
Quantification of oxidized levels of specific RNA species using an aldehyde reactive probeMikiei Tanaka, Song Han, Pascal A Küpfer, et al.
International Clinical Psychopharmacology|April 1, 1986
Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoinP Baumann, M Jonzier-Perey, L Koeb, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1980
A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoinA Küpfer, G M Brilis, J T Watson, et al.
Clinical Pharmacology and Therapeutics|January 1, 1984
Mephenytoin hydroxylation deficiency: kinetics after repeated dosesA Küpfer, P Desmond, R Patwardhan, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanolP G Wells, A Küpfer, J A Lawson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 1998
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in ratsT M Visarius, H Bähler, A Küpfer, et al.
British Journal of Cancer|September 1, 1993
Depletion of circulating cyst(e)ine by oral and intravenous mesnaB Stofer-Vogel, T Cerny, A Küpfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapyB H Lauterburg, T Nguyen, B Hartmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1984
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humansA Küpfer, R Patwardhan, S Ward, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
Analytical Biochemistry|June 23, 2011
Quantification of oxidized levels of specific RNA species using an aldehyde reactive probeMikiei Tanaka, Song Han, Pascal A Küpfer, et al.
International Clinical Psychopharmacology|April 1, 1986
Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoinP Baumann, M Jonzier-Perey, L Koeb, et al.
Pageof 6